Close Banner

Integrative Health

5 Takeaways From The New AHA Heart Health Guidelines You Should Know

Author: Sela Breen

March 18, 2026

Assistant Health Editor

By Sela Breen

Image by Sean Locke / Stocksy

March 18, 2026

The American Heart Association just released its first major cholesterol guideline update in roughly eight years, so if you care about your heart health, or have ever wondered whether you should be doing more to protect it, listen up!

The new guidelines mark a significant shift away from one-size-fits-all recommendations toward a more personalized and proactive approach to care. This includes specific cholesterol targets instead of vague "lower is better" advice, universal screening for little-known genetic risk factors, and much-needed formal recognition that women's reproductive history matters for heart health.

Here's what's changed, what it means for you, and the specific questions to bring to your next doctor's visit.

LDL targets are back (and they're specific)

For years, managing cholesterol felt a bit like aiming at a moving target. The previous guidelines moved away from specific LDL numbers, focusing instead on percentage reductions. But now, once again, the AHA is is giving us concrete goals for our levels.

According to the 2026 AHA guidelines, your LDL-C target now depends on your cardiovascular risk level, which you can figure out using your medical history and test results. It's a great idea to connect with your physician to see which level you reside in.

The new LDL-C targets for each risk category are:

- Moderate risk: Less than 100 mg/dL

- High risk: Less than 70 mg/dL

- Very high risk: Less than 55 mg/dL

Having a specific number to aim for makes it easier to track progress. Instead of wondering if you're doing enough when it comes to your LDL, these numbers allow you to know exactly where you stand.

Everyone should be getting their Lp(a) tested

The new guidelines include a Class 1 recommendation (that's the highest level) for universal Lipoprotein(a), or Lp(a), screening in all adults. Lp(a) is a type of cholesterol particle that's largely determined by your genes. Unlike regular LDL, which responds to diet and lifestyle changes, your Lp(a) level is mostly fixed at birth. High levels significantly increase your risk of heart disease and stroke, and most people have no idea what their number is.

The good news is you only need to test it once in your lifetime, since it doesn't change much. It's a simple blood test that can reveal a hidden risk you didn't know you had. If your level is elevated, your doctor can factor that into your overall risk assessment and treatment plan.

Your CAC score matters more than previously thought

Coronary artery calcium (CAC) scoring has been around for a while, but the new guidelines expand on its importance. CAC is tested via a CT scan that measures the amount of calcified plaque in your coronary arteries, essentially giving you a snapshot of how much atherosclerosis (artery clogging) has already developed.

The guidelines now recognize that incidental coronary artery calcium findings on non-cardiac CT scans (like a chest CT done to diagnose pneumonia) should also be factored into your cardiovascular risk assessment. In other words, if calcium shows up in your arteries during a scan for something else entirely, that information shouldn't be ignored (which should really go without staying, but this is how the system has been functioning.)

CAC scoring is particularly useful for people in the borderline risk category—those who aren't clearly high-risk but aren't low-risk either. A CAC score of zero is reassuring and might mean you can hold off on medication. A higher score could tip the scales toward earlier, more aggressive treatment.

Treatment is becoming less rigid and more personalized

Remember the old "stepladder" approach to cholesterol treatment? Start with lifestyle changes, then add a statin, then maybe add another medication if that's not enough? The new guidelines move away from that rigid sequence.

Instead, clinicians now have more flexibility to combine therapies earlier, including non-statin medications like ezetimibe, bempedoic acid, and PCSK9 inhibitor, based on individual patient needs and how far someone is from their LDL goal.

Perhaps more importantly, the guidelines emphasize lifetime cholesterol exposure rather than just 10-year risk snapshots. This means younger adults with elevated LDL may now qualify for earlier treatment. The thinking is that decades of exposure to high cholesterol can cause cumulative damage, so intervening earlier may prevent problems down the road.

Women's heart health finally gets its due

This might be the most overdue change in the new guidelines. For the first time, reproductive history is formally recognized as a cardiovascular risk factor.

Specifically, the guidelines call out:

- Preeclampsia (high blood pressure during pregnancy)

- Gestational diabetes

- Early menop